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TO THE EDITOR
The derivation of engineered stem cells
or human induced pluripotent stem cells
(iPSCs; Takahashi et al., 2007) through
the reprogramming of adult fibroblasts
was a major advancement in the field of
cell therapeutics and regenerative med-
icine. Introduction of defined transcrip-
tion factors in various combinations
(cMYC, SOX2, OCT4, KLF4, NANOG,
LIN28) has subsequently been used to
reprogram different somatic cell types,
including patient-specific cells, into
iPSCs, with subsequent directed differ-
entiation into various lineages (Kiskinis
and Eggan, 2010). For example, our pre-
vious studies defined conditions under
which keratinocytes can be generated
from iPSC (Itoh et al., 2011).
Despite recent advances, there are
still major challenges associated with
using conventional iPSCs for clinical
applications, for example, reprogram-
ming efficiency is low and viral integra-
tion frequently occurs. To facilitate iPSC
generation, synthetic small molecules
and modified mRNAs are now being
used to replace transcription factors
during reprogramming (Zhu et al.,
2010; Warren et al., 2011). The choice
of cell type also has a significant effect,
e.g., umbilical vein endothelial cells
and amniotic fluid–derived cells possess
higher reprogramming efficiencies when
four transcription factors are used
(Li et al., 2009; Galende et al., 2010;
Panopoulos et al., 2011). Compara-
tively, human fetal neural cells have a
low reprogramming efficiency, but can
be reprogrammed using just one factor,
OCT4 (Kim et al., 2009). However,
accessibility problems render the use of
fetal cells undesirable. Skin keratino-
cytes, in contrast, are highly accessible,
and have been reported as being 100
times more efficient than fibroblasts at
reprogramming (Aasen and Belmonte,
2010).
Here, we assessed the reprogram-
ming potential of another accessible
cell type located within the skin, the hair
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Figure 1. Pluripotency and characterization of DP-iPSCs cell lines. (a) Alkaline phosphatase was observed in DP-iPSC colonies after formation. After
expansion, the transcription factors (b) Sox2 and (c) Oct4 were detected by immunofluorescence. In addition, ESC pluripotency markers (d) tumor-related
antigen 1–81, (e) tumor-related antigen 1–60, and (f) stage-specific embryonic antigen 3 were detected on cell surfaces. (g) ESC pluripotency markers were
detected by reverse transcription–PCR (RT–PCR) in two lines of DP-iPSCs, and in human ESCs, although the majority were not detected within cultured human
DP cells. (h) RT–PCR of endogenous and viral transcription factors indicated that both DP-iPSC lines under analysis expressed endogenous cMYC, SOX2,
OCT4, and KLF4, whereas viral silencing was more random. (i) Karyotype analysis of the DP-iPSCs indicated a normal karyotype of 46XY. (j) Methylation
analysis of the NANOG promoter showed a repressed promoter in cultured DP cells, but an active promoter in ESCs and DP-iPSCs. Bar¼100 mm.
DP, dermal papilla; ESC, embryonic stem cell; Hu, human; iPSC, induced pluripotent stem cell.
Abbreviations: DP, dermal papilla; ESC, embryonic stem cell; iPSC, induced pluripotent stem cell
follicle dermal papilla (DP), to deter-
mine whether they also had an in-
creased reprogramming efficiency. We
focused on the DP, located at the base
of the hair follicle, since it is an
enriched stem cell niche of clinical
interest in other contexts (Hunt et al.,
2008; Biernaskie et al., 2009). When
we analyzed the endogenous levels of
the transcription factors commonly
used in reprogramming, we found high
levels of endogenous SOX2 and
NANOG in intact human DP (Supple-
mentary Figure S1 online). Immuno-
fluorescence analysis of SOX2 con-
firmed these observations, but when
DP cells were propagated in culture
they no longer expressed these pluripo-
tency markers. In this regard, the DP
cells appeared similar to cultured inter-
follicular fibroblasts, however, cultured
DP cells are distinct from fibroblasts
insofar as they demonstrate remarkable
plasticity differentiating down multiple
mesenchymal lineages in culture (Ri-
chardson et al., 2005).
To assess the reprogramming capa-
city of human DP cells, we used pMX-
based retroviruses using varying com-
binations of four transcription factors—
cMYC, SOX2, OCT4, and KLF4 (see
Supplementary Materials and Methods
online)—to transduce DP cells at pas-
sage 3. We observed iPSC colony
formation 28 days after transduction
when we used four factors, resulting in
a reprogramming efficiency ofB0.02%.
However, we were unable to generate
any iPSC colonies using less than four
factors, in any combination, from cul-
tured human DP. Our colonies ap-
peared to be similar to embryonic
stem cells (ESCs) in their appearance,
exhibiting a high nuclear/cytoplasmic
ratio and expressing alkaline phospha-
tase (Figure 1a). After colony expansion,
we observed ESC markers (Supplemen-
tary Table S1 online) localized within
DP-iPSC colonies using immunofluor-
escence (Figure 1b–f). In addition, re-
verse transcription–PCR analysis against
ESC genes (Supplementary Table S2
online) indicated expression within our
DP-iPSCs but not within cultured DP
cells, indicative of successful repro-
gramming (Figure 1g). Reverse tran-
scription–PCR of the reprogramming
factors in their endogenous and viral
forms also showed that although DP-
iPSCs express all four factors endogen-
ously, there is random viral silencing
after DP-iPSC expansion (Figure 1h).
Despite this, the karyotype of our
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Figure 2. Differentiation of DP-iPSCs. After in vitro differentiation of embryoid bodies of DP-iPSCs, immunofluorescence analysis showed expression of
markers characteristic of (a) ectoderm (bIII-tubulin), (b) mesoderm (vimentin), and (c) endoderm (a-fetoprotein). DP-iPSCs were differentiated on PA6
feeder layers down a dopaminergic neuron lineage, and after 14 days expressed neuronal markers (d) paired box 6, (e) bIII-tubulin, and (f) the
dopaminergic neuronal marker tyrosine hydroxylase. After in vivo formation of teratomas, hematoxylin and eosin staining revealed that DP-iPSCs had
differentiated down (g) ectodermal, (h) mesodermal, and (i) endodermal lineages. Bar¼ 100mm. DP, dermal papilla; iPSC, induced pluripotent stem cell.
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DP-iPSCs remained normal after ex-
tended culture (Figure 1i). We also
performed bisulfite sequencing of the
NANOG promoter, and found that
similar to ESCs, DP-iPSCs have an
unmethylated promoter, indicating a
transcriptionally active NANOG status
(Figure 1j). Comparatively, the NANOG
promoter in cultured DP cells is methy-
lated, and therefore silenced.
To interrogate the pluripotency of
our DP-iPSCs, we used both in vitro
and in vivo techniques. First, we used
DP-iPSCs to generate embryoid bodies,
which spontaneously differentiated into
ectodermal, mesodermal, and endodermal
lineages (Figure 2a–c). We also success-
fully directed our DP-iPSCs to differ-
entiate into a neuronal lineage, which
expressed various neuronal markers, in-
cluding the dopaminergic neuron mar-
ker tyrosine hydroxylase (Figure 2d–f).
For in vivo differentiation analysis,
we injected DP-iPSCs subcutaneously
into athymic mice, where they
formed teratomas containing tissues
derived from all three germ lineages
(Figure 2g–i).
In this study, we sought to determine
whether human DP cells may represent
a reprogrammable cell type for use
in generating iPSCs. We were able to
successfully reprogram human hair
follicle DP cells into DP-iPSCs, and
showed their similarity to ESCs. Similar
to ESCs, DP-iPSCs also exhibit pluripo-
tency and can differentiate into various
cell and tissue types in vitro and in vivo.
We conclude that DP cells are indeed
reprogrammable, however, their repro-
gramming efficiency is not significantly
different from adult human fibroblasts
(Takahashi et al., 2007). Thus, unlike
keratinocytes, there is not a significant
improvement in reprogramming effi-
ciency using DP cells rather than
dermal fibroblasts when making hu-
man iPSCs. This is in contrast to
recent reports demonstrating that
mouse DP cells have a significant
reprogramming advantage over
mouse fibroblasts, and are capable
of being reprogrammed using Oct4
alone (Tsai et al., 2011).
One explanation for this difference is
the requirement to expand human DP
cells with an explant method (Ohyama
et al., 2010), which leads to a loss
of SOX2 and NANOG expression
(Supplementary Figure S1 online).
In contrast, mouse DP cells can be
enzymatically dissociated from intact
tissues and transduced shortly after,
allowing for retention of high Sox2
expression (Tsai et al., 2011), which
may partly confer the reprogramming
advantage. Perhaps a more efficient
way of making human iPSCs would be
through reprogramming SKPs, of which
DP cells are an enriched source (Hunt
et al., 2008). Our work underscores the
necessity of conducting studies using
human cells in addition to mouse, in
order to specifically determine their
potential benefit to regenerative medi-
cine. We conclude that the human hair
follicle provides an accessible source of
reprogrammable cells for making iPSCs,
both in the form of outer root sheath
cells that can be isolated from a single
plucked hair fiber, as previously shown
(Aasen and Belmonte, 2010), and here,
for the first time, using cells derived
from the DP.
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